Safety Monitoring of Bivalent COVID ‐19 mRNA Vaccines Among Recipients 6 Months and Older in the United States

• Patricia C. LloydUnited States Food and Drug Administration
• Elizabeth R. SmithAcumen (United States)
• Joann F. GruberUnited States Food and Drug Administration
• Michelle OndariAcumen (United States)
• Hui‐Lee WongUnited States Food and Drug Administration
• Mao HuAcumen (United States)
• Tainya C. ClarkeUnited States Food and Drug Administration
• Rowan McEvoyAcumen (United States)
• Kandace L. Amend
• Daniel C. BeachlerCarelon Research (United States)
• Cheryl N. McMahill‐WalravenCVS Health (United States)
• John D. Seeger
• Alex M. SecoraIQVIA (United States)
• Djeneba Audrey DjiboCVS Health (United States)
• Jennifer Kim Song
• Nandini SelvamIQVIA (United States)
• Jonathan P. DeShazoCVS Health (United States)
• Robin Clifford
• Eugenio J. AbenteCVS Health (United States)
• Yoganand ChillarigeAcumen (United States)
• Richard A. ForsheeUnited States Food and Drug Administration
• Steven A. AndersonUnited States Food and Drug Administration
• Azadeh ShoaibiUnited States Food and Drug Administration